Swedish Infrastructure Stock News

OM:ACAST
OM:ACASTInteractive Media and Services

European Companies Trading Below Estimated Value In April 2026

As European markets continue to digest corporate earnings and geopolitical developments, the pan-European STOXX Europe 600 Index has shown positive momentum, reflecting a broader sense of optimism among investors. In this environment, identifying undervalued stocks can be particularly appealing for investors seeking opportunities that may benefit from improving market sentiment and economic conditions.
OM:NREST
OM:NRESTHospitality

Exploring Three European Undiscovered Gems with Promising Potential

As European markets show resilience with the STOXX Europe 600 Index rising by 1.91% amid geopolitical developments and economic forecasts, investors are increasingly attentive to small-cap opportunities that might benefit from these broader trends. In this context, identifying stocks with strong fundamentals and growth potential becomes crucial for navigating the evolving landscape, particularly those that can capitalize on regional industrial production gains and stable monetary policy...
OM:EQT
OM:EQTCapital Markets

EQT Chair Handover To Jean Eric Salata Puts Global Growth In Focus

EQT AB (OM:EQT) has nominated Jean Eric Salata as the next Chairperson of the Board. Salata is set to succeed current Chairperson Conni Jonsson. The nomination signals an upcoming leadership transition at the top of EQT's governance structure. EQT AB, listed as OM:EQT, operates as an investment manager with a focus on private markets and fund management. A change in the chairperson role sits at the core of how the board oversees capital allocation, risk, and long term priorities, so many...
OM:SOBI
OM:SOBIBiotechs

Does Health Canada’s EMPAVELI Approval in C3G and IC-MPGN Change The Bull Case For Sobi (OM:SOBI)?

Swedish Orphan Biovitrum (Sobi) and partner Apellis Pharmaceuticals have received Health Canada approval for EMPAVELI (pegcetacoplan) to treat rare kidney diseases C3 glomerulopathy and primary IC-MPGN in patients aged 12 and older, based on Phase 3 VALIANT data showing reduced proteinuria, stabilized kidney function, and clearance of C3 deposits. This decision extends EMPAVELI’s nephrology footprint beyond the US and EU into Canada, adding another rare-disease indication to Sobi’s portfolio...
OM:SKF B
OM:SKF BMachinery

What AB SKF (OM:SKF B)'s Mexico Plant Closure and Production Shift Means For Shareholders

AB SKF recently announced it will close its shared Automotive and Industrial factory in Monterrey, Mexico, shifting production to its Puebla and La Silla plants as part of the ongoing separation of its Automotive business and a consolidation of its Americas manufacturing footprint. This reconfiguration responds to lower-than-anticipated electric vehicle demand and aims to align capacity with each division’s needs while incurring about SEK 0.50 billion in consolidation costs and cutting...
OM:ERIC B
OM:ERIC BCommunications

Evaluating Ericsson (OM:ERIC B) After Strong Returns And Mixed Signals On Valuation

Telefonaktiebolaget LM Ericsson (OM:ERIC B) has drawn investor attention after recent share price moves, with the stock showing a mix of short term weakness and stronger performance over the past year. See our latest analysis for Telefonaktiebolaget LM Ericsson. At the current share price of SEK105.7, the stock has seen short term share price pressure, including a 1 day share price return decline of 4.13%, while longer term momentum remains positive with a 1 year total shareholder return of...
OM:MILDEF
OM:MILDEFAerospace & Defense

MilDef Group (OM:MILDEF) Valuation Check After Strong 2026 Q1 Revenue And Margin Guidance

MilDef Group (OM:MILDEF) has drawn investor attention after issuing first quarter 2026 guidance indicating approximately SEK 700 million in revenue and an EBITA margin near 17%, compared with SEK 340 million and 4.6% a year earlier. See our latest analysis for MilDef Group. These guidance figures arrive as MilDef Group's 7 day share price return of 41.99% and 30 day share price return of 48.25% push the share price to SEK181.75, while the 1 year total shareholder return of 20.54% decline...
OM:SKA B
OM:SKA BConstruction

Is It Time To Reassess Skanska (OM:SKA B) After Its Strong One Year Share Price Run?

If you are wondering whether Skanska's current share price reflects its true worth, starting with a clear look at valuation can help you frame that decision. Skanska's stock last closed at SEK 263.2, with returns of 2.9% over 7 days, 2.4% over 30 days, 2.1% year to date, 33.6% over 1 year, 86.3% over 3 years and 44.3% over 5 years, which gives you a useful backdrop before comparing price to value. Recent coverage around Skanska has focused on the company as a key name in the Swedish...
OM:SLP B
OM:SLP BReal Estate

Swedish Logistic Property (OM:SLP B) Is Up 8.9% After Essity Lease And Q1 2026 Earnings Beat – Has The Bull Case Changed?

Swedish Logistic Property AB recently reported first-quarter 2026 results showing sales of SEK 296 million and net income of SEK 231 million, while also appointing Annie Franzon to its board and signing an 8-year lease with Essity for up to approximately 30,000 square meters in Falkenberg. The combination of higher quarterly revenues, a long-term lease with an established tenant, and ongoing board strengthening highlights how Swedish Logistic Property is working to support recurring rental...